Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × ponatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms 6 Leukemia 5 Neoplasms by Histologic Type 4 Myeloproliferative Disorders 4 Leukemia, Myeloid 4 Hematologic Diseases 4 Bone Marrow Diseases 4 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myeloid, Chronic-Phase 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Piebaldism 1 Malignant Hepatobiliary Neoplasm 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Carcinoma, Squamous Cell 1 Blast Crisis 1 Adenocarcinoma of Lung 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 24 Whole-Body Irradiation 19 Mycophenolic Acid 19 Tacrolimus 16 Busulfan 16 ruxolitinib 15 Peripheral Blood Stem Cell Transplantation 14 Antilymphocyte Serum 14 fludarabine 13 Melphalan 12 Cyclosporine 10 thymoglobulin 9 Methotrexate 9 Sirolimus 6 Etoposide 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 Azacitidine 4 pomalidomide 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 parsaclisib 2 itacitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡